Chloroquine kills COVID-19 virus in early stages, says NAFDAC- NAFDAC says chloroquine can kill COVID-19 at the early stage of the virus - This was disclosed by the agency's director-general, Professor Mojisola Adeyeye - Professor Adeyeye said the information is based on recent reliable researches and reports PAY ATTENTION: Click “See First” under the “Following” tab to see Legit.ng News on your Facebook News Feed! The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Adeyeye, has revealed that reliable researches and reports show chloroquine can kill COVID-19 at the early stage of the virus. According to the NAFDAC boss, remdesivir, an antiviral medication, has also been shown to kill the virus at late stages. The NAFDAC boss, however, noted the cost for treating people with chloroquine was way cheaper than remdesivir. PAY ATTENTION: Download our mobile app to enjoy the latest news update “While remdesivir cost $2,500 to treat an average patient, chloroquine only cost $10,” she revealed. Read also Coronavirus: Traders reveal hike in cost of food items as Easter beckons She also noted West African nations like Ghana, Togo and Senegal have embraced the clinical use of chloroquine for treatment. Professor Adeyeye disclosed these during a virtual press conference on Tuesday, August 25 in Abuja. Her words: “In the cells, in the lab, remdesivir and chloroquine killed COVID-19. At what stage would they be more effective? We didn’t know at that point. Now we are realising that chloroquine is effective at the early stage. “Remember, remdesivir and chloroquine work in the cells. Chloroquine was proven to work in 100 patients. We did not know at that time that the disease has about four phases – pre-exposure stage, early stage, mild stage, and the severe stage. “When we now got the profile of remdesivir, what was recorded in literature and from the manufacturer was that remdesivir doesn’t work at the early stage. It works at the late stage. “But when viruses are in the tube in the laboratory, you won’t know which is late or which is early. Both killed them. We are now understanding that it is not only one drug that can be effective for COVID-19 but it depends on the stage and the phases of the disease.” Read also N10 billion fraud allegation: IGP orders probe of Udom’s appointee Recall that Professor Adeyeye recently declared that Nigeria will continue with hydroxychloroquine trials for the treatment of COVID-19. The statement by Adeyeye came after the World Health Organisation ordered the trial to be stopped throughout the globe. However, the NAFDAC boss said that the pill has proven strong enough to cure coronavirus at its emergent stage, according to data released by the agency. Legit.ng had earlier reported NAFDAC's insistence that it has only received one application to endorse a product as a possible treatment option for the symptoms of COVID-19 in Nigeria. The agency was responding to the barrage of claims by some traditional practitioners that they have the cure for the virus. In a statement issued on Wednesday, May 13, Professor Adeyeye said other claims about a possible cure for COVID-19 only exist on social media and the pages of newspapers. Covid-19: Trump fulfills promise to Nigeria, presents 200 Ventilators to health ministry | Legit TV Read also Kogi guber: Huge number of APC aspirants is due to my efforts, says Gov Bello Source: Legit.ng - NAFDAC says chloroquine can kill COVID-19 at the early stage of the virus - This was disclosed by the agency's director-general, Professor Mojisola Adeyeye - Professor Adeyeye said the information is based on recent reliable researches and reports PAY ATTENTION: PAY ATTENTION: Legit.ng